产品详情
Targets
Target | Value |
---|---|
PDGFRβ | IC50: 1nM |
PDGFRα | IC50: 10nM |
c-Kit | IC50: 252nM |
VEGFR1 | IC50: 450nM |
VEGFR2 | IC50: 450nM |
LCK | IC50: >1μM |
Src | IC50: >2μM |
v-Abl | IC50: >5μM |
Tie-2 | IC50: >5μM |
bFGFR | IC50: >5μM |
EGFR | IC50: >10μM |
ErbB2 | IC50: >10μM |
c-Met | IC50: >10μM |
IGF-1R | IC50: >10μM |
In vitro (25°C) | DMSO | Warmed: 28 mg/mL (67.06 mM) | |
Water | Insoluble | ||
Ethanol | 4 mg/mL | ||
In vivo | 5%DMSO+40%PEG300+5%Tween80+50%ddH2O | 2.3 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 23.95 mL | 119.76 mL | 239.52 mL |
0.5 mM | 4.79 mL | 23.95 mL | 47.9 mL |
1 mM | 2.4 mL | 11.98 mL | 23.95 mL |
5 mM | 0.48 mL | 2.4 mL | 4.79 mL |
*The above data is based on the productmolecular weight 417.5. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A11350 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 417.5 |
Formula | C24H27N5O2 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 343787-29-1 |
Synonyms | CP673451 |
SMILES | COCCOC1=CC2=C(C=C1)N(C=N2)C3=NC4=C(C=CC=C4N5CCC(CC5)N)C=C3 |
产品标签
Product Questions
Product Questions
Linifanib (ABT-869)
Linifanib (ABT-869)是一种结构新颖的有效RTK,VEGF和PDGF抑制剂,对人内皮细胞,PDGFR-β,KDR和CSF-1R的IC50分别为0.…
Toceranib (PHA 291639, SU 11654)
Toceranib (PHA 291639,SU 11654)是一种激酶抑制剂,通过抑制KIT,血管内皮生长因子受体2和PDGFRβ同时具有抗肿瘤…
Regorafenib (BAY 73-4506)
Regorafenib (BAY 73-4506)是一种多激酶抑制剂,IC50为17、40和69 nM c-KIT,VEGFR2,B-Raf。Regorafenib(BAY 73-4506)是一种…
AC710 Mesylate
AC710 Mesylate是一种有效的选择性PDGFR家族激酶抑制剂,对于FLT3/KIT/PDGFRα/PDGFRβ的Kd值分别为0.6 nM/1.0 nM/1.3 nM/1.…
Pazopanib (GW-786034)
Pazopanib (GW-786034)是VEGFR-1,VEGFR-2,VEGFR-3,PDGFR-a/β和c-kit的有效且选择性的多靶点酪氨酸激酶抑制剂,可阻…
N-Desethyl Sunitinib
N-Desethyl Sunitinib是舒尼替尼的主要药理活性代谢产物,是有效的,ATP竞争性VEGFR,PDGFRβ和KIT抑制剂(VEGFR -1…
Sunitinib Malate
Sunitinib Malate是一种多靶点RTK抑制剂,作用于VEGFR2 (Flk-1)和 PDGFRβ,也会抑制c-Kit的活性。用于治疗肾细胞癌…